The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery
- Conditions
- Surgical Site Infection
- Interventions
- Other: Wound dressing removal.
- Registration Number
- NCT02902419
- Lead Sponsor
- Albany Medical College
- Brief Summary
A randomized controlled trial measuring surgical site infection rate as a function of timing of wound dressing removal.
- Detailed Description
A randomized controlled trial with a sample size of 602 patients to study the effect of timing of wound dressing removal on the surgical site infection rate. 300 patients were randomized to a group that had the wound dressing removed between 12-30 hours postoperatively. 302 patients were randomized to a group that had the wound dressing removal between 30-48 hours postoperatively. Statistical analyses were performed to determine if the timing of dressing removal had statistical significance on the surgical site infection rate, the primary outcome.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 602
- patients ages 18-50 years;
- medically competent (no proxies or prisoners); and
- multifetal and singleton gestations from 23 0/7 weeks to 42 0/7 weeks gestational age.
- Inability to obtain informed consent;
- fetal death;
- immunocompromised patients; patients taking immuno-suppressants; history of documented surgical site infection; or patients requiring reoperation within the 6 week postoperative period for indications other than wound dehiscence/debridement/infection.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Wound dressing removal. Wound dressing removal was performed between 30-48 hours postoperatively. 1 Wound dressing removal. Wound dressing removal was performed between 12-30 hours postoperatively.
- Primary Outcome Measures
Name Time Method Surgical Site infection Rate 6 weeks postoperatively Cellulitis, purulent drainage, abscess or wound requiring drainage, debridement, and antibiotics associated with a clinical diagnosis of infection. Any disruption of fascia or subcutaneous skin.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
St. Peter's Hospital
🇺🇸Albany, New York, United States
Bellevue Women's Center
🇺🇸Niskayuna, New York, United States